Ballentine Partners, LLC Becton Dickinson & CO Transaction History

Ballentine Partners, LLC

  • $7.1 Billion
  • Q3 2025

A detailed history of Ballentine Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ballentine Partners, LLC holds 3,181 shares of BDX stock, worth $607,507. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,181
Previous 2,875 10.64%
Holding current value
$607,507
Previous $495,000 20.2%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
BUY
$172.41 - $199.66 $52,757 - $61,095
306 Added 10.64%
3,181 $595,000
Q2 2025

Jul 15, 2025
BUY
$165.15 - $226.42 $23,781 - $32,604
144 Added 5.27%
2,875 $495,000
Q1 2025

May 01, 2025
SELL
$222.79 - $249.08 $174,221 - $194,780
-782 Reduced 22.26%
2,731 $625,000
Q4 2024

Jan 16, 2025
BUY
$220.02 - $243.75 $48,844 - $54,112
222 Added 6.75%
3,513 $796,000
Q3 2024

Oct 23, 2024
BUY
$221.47 - $242.41 $72,420 - $79,268
327 Added 11.03%
3,291 $793,000
Q2 2024

Aug 06, 2024
SELL
$225.07 - $246.17 $138,643 - $151,640
-616 Reduced 17.21%
2,964 $692,000
Q1 2024

Apr 11, 2024
SELL
$233.45 - $247.73 $252,359 - $267,796
-1,081 Reduced 23.19%
3,580 $885,000
Q4 2023

Jan 23, 2024
SELL
$232.24 - $267.23 $30,423 - $35,007
-131 Reduced 2.73%
4,661 $1.14 Million
Q3 2023

Oct 19, 2023
SELL
$254.9 - $283.59 $32,882 - $36,583
-129 Reduced 2.62%
4,792 $1.24 Million
Q2 2023

Jul 26, 2023
SELL
$238.39 - $265.32 $66,510 - $74,024
-279 Reduced 5.37%
4,921 $1.3 Million
Q1 2023

Apr 27, 2023
BUY
$229.71 - $259.35 $350,307 - $395,508
1,525 Added 41.5%
5,200 $1.29 Million
Q4 2022

Jan 27, 2023
SELL
$218.29 - $256.91 $22,702 - $26,718
-104 Reduced 2.75%
3,675 $0
Q3 2022

Oct 26, 2022
BUY
$51.03 - $264.23 $15,615 - $80,854
306 Added 8.81%
3,779 $842,000
Q2 2022

Aug 09, 2022
SELL
$234.74 - $275.42 $194,599 - $228,323
-829 Reduced 19.27%
3,473 $856,000
Q1 2022

May 05, 2022
BUY
$243.64 - $270.48 $236,330 - $262,365
970 Added 29.11%
4,302 $1.15 Million
Q4 2021

Feb 14, 2022
SELL
$230.08 - $250.94 $152,082 - $165,871
-661 Reduced 16.55%
3,332 $839,000
Q3 2021

Oct 27, 2021
BUY
$232.72 - $256.47 $226,203 - $249,288
972 Added 32.17%
3,993 $982,000
Q2 2021

Aug 12, 2021
SELL
$232.65 - $254.58 $40,713 - $44,551
-175 Reduced 5.48%
3,021 $735,000
Q1 2021

May 11, 2021
BUY
$232.09 - $256.88 $30,867 - $34,165
133 Added 4.34%
3,196 $777,000
Q4 2020

Jan 25, 2021
BUY
$221.92 - $245.94 $32,178 - $35,661
145 Added 4.97%
3,063 $766,000
Q3 2020

Oct 22, 2020
BUY
$215.77 - $276.76 $6,041 - $7,749
28 Added 0.97%
2,918 $679,000
Q2 2020

Jul 31, 2020
BUY
$219.9 - $263.41 $52,556 - $62,954
239 Added 9.02%
2,890 $692,000
Q1 2020

Apr 23, 2020
SELL
$195.69 - $279.01 $32,093 - $45,757
-164 Reduced 5.83%
2,651 $610,000
Q4 2019

Jan 22, 2020
BUY
$236.45 - $266.82 $15,369 - $17,343
65 Added 2.36%
2,815 $766,000
Q3 2019

Oct 21, 2019
BUY
$230.58 - $256.08 $53,725 - $59,666
233 Added 9.26%
2,750 $696,000
Q2 2019

Jul 25, 2019
BUY
$217.4 - $246.08 $61,959 - $70,132
285 Added 12.77%
2,517 $635,000
Q1 2019

May 09, 2019
BUY
$206.05 - $248.17 $10,302 - $12,408
50 Added 2.29%
2,232 $558,000
Q4 2018

Feb 04, 2019
SELL
$204.73 - $257.93 $17,606 - $22,181
-86 Reduced 3.79%
2,182 $491,000
Q3 2018

Oct 30, 2018
BUY
$233.07 - $256.0 $466 - $512
2 Added 0.09%
2,268 $592,000
Q2 2018

Jul 19, 2018
BUY
$208.1 - $233.85 $17,480 - $19,643
84 Added 3.85%
2,266 $543,000
Q1 2018

Apr 26, 2018
BUY
$205.46 - $240.27 $8,423 - $9,851
41 Added 1.91%
2,182 $473,000
Q4 2017

Feb 02, 2018
SELL
$189.0 - $222.64 $69,741 - $82,154
-369 Reduced 14.7%
2,141 $458,000
Q3 2017

Nov 06, 2017
BUY
$186.89 - $198.9 $469,093 - $499,239
2,510
2,510 $493,000

Others Institutions Holding BDX

# of Institutions
1,721
Shares Held
261M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email